CANCER CENTER SUPPORT GRANT

癌症中心支持补助金

• 批准号: 7917747
• 负责人: EDWARD J BENZ
• 金额: $ 14.34万
• 依托单位: DANA-FARBER CANCER INST
• 依托单位国家: 美国
• 财政年份: 1977
• 资助国家: 美国
• 起止时间: 1977-12-01 至 2010-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7917747
• 关键词: Agreement; Basic Cancer Research; Cancer Burden; Cancer Center; Cancer Center Support Grant; Child; Clinical; Communities; Core Facility; Dana-Farber Cancer Institute; Diagnosis; Discipline; Disorder by Site; General Hospitals; Goals; Grant; Institution; Israel; Lead; Link; Malignant Neoplasms; Massachusetts; Medical; NCI-Designated Cancer Center; Population; Population Sciences; Public Health; Research; Resource Sharing; Scientist; Woman; anticancer research; base; cancer prevention; cost; design; experience; medical schools; member; novel strategies; organizational structure; programs

DESCRIPTION (provided by applicant): Dana Farber/Harvard Cancer Center (DF/HCC) is an inter-institutional research enterprise that unites the major clinical, population, and basic cancer research efforts of the Harvard medical and public health community. It was founded in 1998 through a formal agreement of the Dana-Farber Cancer Institute, the Harvard Medical School and Harvard School of Medicine and Public Health, and the Beth Israel Deaconess, Brigham and Women's, Children's, and Massachusetts General Hospitals. By agreement, this will be the only NCI-designated Cancer Center application from these institutions. The DF/HCC links the efforts of a large cadre of cancer scientists - currently more than 800 members with NCI grants amounting to more than $200 million in total costs-in an interlocking organizational structure designed to promote research advances that are aimed at lowering the burden of cancer. In the aggregate, Center members have extensive experience and well-recognized expertise in the three major cancer research disciplines: basic, clinical, and population science. The research of the Center is carried out in 17 disease site- and discipline-based Research Programs that cross both institutional and scientific boundaries. In addition, the Center supports 19 Core Facilities that make shared resources, dedicated to enhancing scientific efficiency, available to all Center members. The primary goal of the Center is to promote collaborative interactions that will lead to new approaches to cancer prevention, diagnosis, and treatment.

描述（由申请人提供）：Dana Farber/Harvard癌症中心（DF/HCC）是一家机构间研究企业，与哈佛医学和公共卫生社区的主要临床，人群和基本癌症研究工作结合在一起。 它成立于1998年，通过达纳 - 法伯癌症研究所，哈佛医学院和哈佛医学与公共卫生学院以及贝丝以色列执事，杨百翰和妇女，儿童，儿童和马萨诸塞州通用医院的正式协议。 通过同意，这将是这些机构唯一的NCI指定的癌症中心应用。 DF/HCC链接了大量癌症科学家的努力 - 目前有800多名NCI赠款成员的总成本超过2亿美元，涉及旨在促进旨在降低癌症负担的研究进展的互锁组织结构。 在总体中，中心成员在三个主要的癌症研究学科中拥有丰富的经验和公认的专业知识：基础，临床和人口科学。 该中心的研究是在跨越机构和科学界限的17个基于疾病和学科的研究计划中进行的。 此外，该中心还支持19个核心设施，这些核心设施将共享资源，致力于提高所有中心成员的科学效率。 该中心的主要目标是促进协作互动，这将导致预防癌症，诊断和治疗的新方法。